otsuka pharma compound sodium lactate and sorbitol injection 500ml per bag

Description

Indication & Scope

Compound Sodium Lactate and Sorbitol Injection is a prescription intravenous electrolyte replacement solution indicated for the prevention and treatment of extracellular fluid loss, dehydration, electrolyte imbalance, and mild metabolic acidosis. It also provides a source of calories through sorbitol, making it suitable for patients who require fluid replacement while avoiding glucose administration, including selected patients with diabetes under medical supervision.

Mechanism: The solution replenishes extracellular fluid and electrolytes. Sodium lactate is metabolized to bicarbonate, helping correct metabolic acidosis, while sorbitol serves as a non-glucose energy source after hepatic metabolism.
Drug class: Intravenous electrolyte and fluid replacement solution.
Clinical use: Used for dehydration associated with vomiting, diarrhea, surgery, trauma, perioperative fluid replacement, and metabolic acidosis requiring simultaneous electrolyte and calorie supplementation.

Specification

Generic Name	Compound Sodium Lactate and Sorbitol Injection
Brand Name	Otsuka Pharma®
Ingredient	Sodium lactate, sodium chloride, potassium chloride, calcium chloride dihydrate, sorbitol
Dosage Form	Injection
Package	500 ml/bag
Conditions Treated	Dehydration, extracellular fluid loss, electrolyte imbalance, mild metabolic acidosis
Taboos	Hyperlactatemia, severe renal failure with anuria, severe heart failure, hereditary fructose intolerance, hypersensitivity to any ingredient
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 30°C. Protect from freezing and excessive heat.
Manufacturer	Guangdong Otsuka Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H12020008
Approval Date	June 16, 2025
Shelf Life	24 months

How to use ?

Recommended Dose: Administer by intravenous infusion. The dose and infusion rate should be individualized according to the patient’s fluid deficit, electrolyte status, and clinical condition.

Time: Infuse at an appropriate rate under medical supervision. Slower infusion is recommended for elderly patients or those with cardiac or renal impairment.

Instructions for use: For intravenous use only. Monitor serum electrolytes, acid-base balance, urine output, and fluid status during treatment.

Interaction: Avoid mixing with incompatible alkaline solutions or medications that may cause calcium precipitation. Monitor electrolytes when used with diuretics or potassium-containing products.

Side effects: Possible adverse reactions include fluid overload, electrolyte disturbances, nausea, headache, infusion-site reactions, and, rarely, metabolic alkalosis or hyperlactatemia in susceptible patients.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is Compound Sodium Lactate and Sorbitol Injection used for?

It is used to replace fluids and electrolytes, correct mild metabolic acidosis, and provide calories in patients with dehydration or extracellular fluid loss.

Why does Compound Sodium Lactate and Sorbitol Injection contain sorbitol instead of glucose?

Sorbitol provides energy without directly increasing blood glucose, making it suitable for selected patients who require glucose-free fluid replacement.

Can diabetic patients receive Compound Sodium Lactate and Sorbitol Injection?

Yes. Because it contains sorbitol rather than glucose, it may be considered for diabetic patients when clinically appropriate, under physician supervision.

Is Compound Sodium Lactate and Sorbitol Injection suitable for severe kidney or heart failure?

No. Patients with severe renal failure, anuria, or severe heart failure should generally not receive this solution because of the risk of fluid overload and electrolyte imbalance.

Otsuka Pharma® | Compound Sodium Lactate and Sorbitol | Electrolyte Replacement | DengYueRX

INN: Compound Sodium Lactate and Sorbitol Injection
Indications: Fluid and electrolyte replacement
Dosage Form: Injection
Strength: 500 mL

Original price was: $14.12.Current price is: $12.00.